246 related articles for article (PubMed ID: 16245686)
1. [The possible place of autologus cell therapy in facioscapulohumeral muscular dystrophy].
Desnuelle C; Sacconi S; Marolleau JP; Larghero J; Vilquin JT
Bull Acad Natl Med; 2005 Apr; 189(4):697-713; discussion 713-4. PubMed ID: 16245686
[TBL] [Abstract][Full Text] [Related]
2. Normal growth and regenerating ability of myoblasts from unaffected muscles of facioscapulohumeral muscular dystrophy patients.
Vilquin JT; Marolleau JP; Sacconi S; Garcin I; Lacassagne MN; Robert I; Ternaux B; Bouazza B; Larghero J; Desnuelle C
Gene Ther; 2005 Nov; 12(22):1651-62. PubMed ID: 15973444
[TBL] [Abstract][Full Text] [Related]
3. Isolation and characterization of mesoangioblasts from facioscapulohumeral muscular dystrophy muscle biopsies.
Morosetti R; Mirabella M; Gliubizzi C; Broccolini A; Sancricca C; Pescatori M; Gidaro T; Tasca G; Frusciante R; Tonali PA; Cossu G; Ricci E
Stem Cells; 2007 Dec; 25(12):3173-82. PubMed ID: 17761758
[TBL] [Abstract][Full Text] [Related]
4. Expression profiling of FSHD muscle supports a defect in specific stages of myogenic differentiation.
Winokur ST; Chen YW; Masny PS; Martin JH; Ehmsen JT; Tapscott SJ; van der Maarel SM; Hayashi Y; Flanigan KM
Hum Mol Genet; 2003 Nov; 12(22):2895-907. PubMed ID: 14519683
[TBL] [Abstract][Full Text] [Related]
5. FRG2, an FSHD candidate gene, is transcriptionally upregulated in differentiating primary myoblast cultures of FSHD patients.
Rijkers T; Deidda G; van Koningsbruggen S; van Geel M; Lemmers RJ; van Deutekom JC; Figlewicz D; Hewitt JE; Padberg GW; Frants RR; van der Maarel SM
J Med Genet; 2004 Nov; 41(11):826-36. PubMed ID: 15520407
[TBL] [Abstract][Full Text] [Related]
6. Expression profile of FSHD supports a link between retinal vasculopathy and muscular dystrophy.
Osborne RJ; Welle S; Venance SL; Thornton CA; Tawil R
Neurology; 2007 Feb; 68(8):569-77. PubMed ID: 17151338
[TBL] [Abstract][Full Text] [Related]
7. Mesoangioblasts from facioscapulohumeral muscular dystrophy display in vivo a variable myogenic ability predictable by their in vitro behavior.
Morosetti R; Gidaro T; Broccolini A; Gliubizzi C; Sancricca C; Tonali PA; Ricci E; Mirabella M
Cell Transplant; 2011; 20(8):1299-313. PubMed ID: 21176400
[TBL] [Abstract][Full Text] [Related]
8. Testing the position-effect variegation hypothesis for facioscapulohumeral muscular dystrophy by analysis of histone modification and gene expression in subtelomeric 4q.
Jiang G; Yang F; van Overveld PG; Vedanarayanan V; van der Maarel S; Ehrlich M
Hum Mol Genet; 2003 Nov; 12(22):2909-21. PubMed ID: 14506132
[TBL] [Abstract][Full Text] [Related]
9. FSHD-like patients without 4q35 deletion.
Yamanaka G; Goto K; Ishihara T; Oya Y; Miyajima T; Hoshika A; Nishino I; Hayashi YK
J Neurol Sci; 2004 Apr; 219(1-2):89-93. PubMed ID: 15050443
[TBL] [Abstract][Full Text] [Related]
10. Methylation of the FSHD syndrome-linked subtelomeric repeat in normal and FSHD cell cultures and tissues.
Tsien F; Sun B; Hopkins NE; Vedanarayanan V; Figlewicz D; Winokur S; Ehrlich M
Mol Genet Metab; 2001 Nov; 74(3):322-31. PubMed ID: 11708861
[TBL] [Abstract][Full Text] [Related]
11. Facioscapulohumeral muscular dystrophy. Phenotype-genotype correlation in patients with borderline D4Z4 repeat numbers.
Butz M; Koch MC; Müller-Felber W; Lemmers RJ; van der Maarel SM; Schreiber H
J Neurol; 2003 Aug; 250(8):932-7. PubMed ID: 12928911
[TBL] [Abstract][Full Text] [Related]
12. Myoblasts from affected and non-affected FSHD muscles exhibit morphological differentiation defects.
Barro M; Carnac G; Flavier S; Mercier J; Vassetzky Y; Laoudj-Chenivesse D
J Cell Mol Med; 2010 Jan; 14(1-2):275-89. PubMed ID: 18505476
[TBL] [Abstract][Full Text] [Related]
13. [Facioscapulohumeral muscular dystrophy. The spectrum of clinical manifestations and molecular genetic changes].
Krasnianski M; Neudecker S; Eger K; Schulte-Mattler W; Zierz S
Nervenarzt; 2003 Feb; 74(2):151-8. PubMed ID: 12596016
[TBL] [Abstract][Full Text] [Related]
14. Myoblast transfer therapy: is there any light at the end of the tunnel?
Mouly V; Aamiri A; Périé S; Mamchaoui K; Barani A; Bigot A; Bouazza B; François V; Furling D; Jacquemin V; Negroni E; Riederer I; Vignaud A; St Guily JL; Butler-Browne GS
Acta Myol; 2005 Oct; 24(2):128-33. PubMed ID: 16550930
[TBL] [Abstract][Full Text] [Related]
15. iMyoblasts for ex vivo and in vivo investigations of human myogenesis and disease modeling.
Guo D; Daman K; Chen JJ; Shi MJ; Yan J; Matijasevic Z; Rickard AM; Bennett MH; Kiselyov A; Zhou H; Bang AG; Wagner KR; Maehr R; King OD; Hayward LJ; Emerson CP
Elife; 2022 Jan; 11():. PubMed ID: 35076017
[TBL] [Abstract][Full Text] [Related]
16. Premature proliferative arrest of cricopharyngeal myoblasts in oculo-pharyngeal muscular dystrophy: Therapeutic perspectives of autologous myoblast transplantation.
Périé S; Mamchaoui K; Mouly V; Blot S; Bouazza B; Thornell LE; St Guily JL; Butler-Browne G
Neuromuscul Disord; 2006 Nov; 16(11):770-81. PubMed ID: 17005403
[TBL] [Abstract][Full Text] [Related]
17. Osteopontin and skeletal muscle myoblasts: association with muscle regeneration and regulation of myoblast function in vitro.
Uaesoontrachoon K; Yoo HJ; Tudor EM; Pike RN; Mackie EJ; Pagel CN
Int J Biochem Cell Biol; 2008; 40(10):2303-14. PubMed ID: 18490187
[TBL] [Abstract][Full Text] [Related]
18. Severe phenotype in infantile facioscapulohumeral muscular dystrophy.
Klinge L; Eagle M; Haggerty ID; Roberts CE; Straub V; Bushby KM
Neuromuscul Disord; 2006 Oct; 16(9-10):553-8. PubMed ID: 16934468
[TBL] [Abstract][Full Text] [Related]
19. Defective regulation of microRNA target genes in myoblasts from facioscapulohumeral dystrophy patients.
Dmitriev P; Stankevicins L; Ansseau E; Petrov A; Barat A; Dessen P; Robert T; Turki A; Lazar V; Labourer E; Belayew A; Carnac G; Laoudj-Chenivesse D; Lipinski M; Vassetzky YS
J Biol Chem; 2013 Dec; 288(49):34989-5002. PubMed ID: 24145033
[TBL] [Abstract][Full Text] [Related]
20. Genotype-phenotype study in an FSHD family with a proximal deletion encompassing p13E-11 and D4Z4.
Deak KL; Lemmers RJ; Stajich JM; Klooster R; Tawil R; Frants RR; Speer MC; van der Maarel SM; Gilbert JR
Neurology; 2007 Feb; 68(8):578-82. PubMed ID: 17229919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
